PharmaSynergy Korea 민국

PharmaSynergy-Korea is taking place on February 23-24 in Amsterdam (and online)

PharmaSynergy Korea is a global partnering event for pharma and biopharma BD & Licensing executives which will help foster overseas partnerships and international business development. PharmaSynergy Korea is a powerful combination of pre-arranged one-2-one meetings and a stimulating programme that highlights partnership case studies, expansion/entry strategies, registration processes and go-to-market considerations, as well as best practice of how such agreements are reached, including the practical aspects that are instrumental to success.

Product portfolio focus:

  • Biosimilars & biobetters
  • Speciality medicines, injectables, general medicine


  • South Korea + worldwide

Key topics:

  • Exploring the potential of Korean Specialty Medications and injectables
  • International growth and cross-border deals in general medicine segments
  • Overview of South Korean programmes that are focused on promoting the development of biosimilars and bio-betters



About PharmaSynergy-Korea

The objective of the event is to highlight and foster international discussions for BD & Licensing deals and to facilitate partnership meetings with overseas companies interested in establishing licensing agreements with Korean market players.

Efficient partnering meetings with senior BD & Licensing executives from around the globe.

With 15% of CEO/MD/GM, 47% - SVP/ Head of BD and 38% of BD Manager level – your conversations convert fast. Some of the past attending companies are listed below.